Date Time
Brexit puts UK health care at risk
The future for the health sector in the United Kingdom is perilously uncertain, according to a comprehensive report by a cross-national team of researchers.
Understanding the impact of Brexit on health in the UK, published by U.K. think tank Nuffield Trust, builds on four years of research on the potential effects of Brexit. It was conducted by University of Michigan faculty members Holly Jarman and Scott Greer of the Department of Health Management and Policy at the School of Public Health and colleagues from the University of Oxford and University of Sheffield.
âPerilously uncertainâ future for UK health sector despite Brexit deal, expert analysis reveals New barriers to migration, disruption to medicines and economic slowdown will impact the health sector almost immediately and into the future. Press release Published: 22/12/2020
The perilously uncertain future facing the UK at the end of the Brexit transition period could put the UKâs health and care system at risk.
New barriers to migration, an unknown level of disruption to medicines and devices, a prolonged economic slowdown and barriers to investment in science will impact the health sector almost immediately and into the future.
Thatâs according to the most comprehensive study to date looking at the issues remaining for health in the UK after the country cuts its ties with the EU in January. The research,
A
Drug regulators only have two speeds, as an old gag puts it: Too fast, and too slow. That’s certainly the perception in this pandemic.
As Western nations begin to roll out the first batch of promising vaccines against Covid-19, with the UK leading the charge and the US the latest to follow suit, the gatekeepers whose job it is to supervise their efficacy, safety and distribution are in a very tough spot.
The pressure to go fast is immense. This once-in-a-century pandemic has claimed over 1 million lives worldwide. Lack of a cure has led to medieval-style, economy-crushing lockdowns. The likes of Donald Trump regularly berate regulators for perceived slowness.
Dec 11 2020, 7:22 PM
December 11 2020, 12:58 PM
December 11 2020, 7:22 PM
(Bloomberg Opinion) Drug regulators only have two speeds, as an old gag puts it: Too fast, and too slow. Thatâs certainly the perception in this pandemic.
(Bloomberg Opinion) Drug regulators only have two speeds, as an old gag puts it: Too fast, and too slow. Thatâs certainly the perception in this pandemic.
As Western nations begin to roll out the first batch of promising vaccines against Covid-19, with the U.K. leading the charge and the U.S. the latest to follow suit, the gatekeepers whose job it is to supervise their efficacy, safety and distribution are in a very tough spot.
Breaking news, live coverage, investigations, analysis, video, photos and opinions from The Washington Post. Subscribe for the latest on U.S. and international news, politics, business, technology, climate change, health and wellness, sports, science, weather, lifestyle and more.